Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
- PMID: 34177537
- PMCID: PMC8215969
- DOI: 10.1159/000515475
Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
Abstract
Amyloidosis is a disorder caused by extracellular tissue deposition of insoluble fibrils. Amyloidosis can be divided into systemic or localized disease. Primary systemic amyloidosis is a multisystem disease caused by the deposition of amyloid in various tissues. Localized amyloidosis has different characteristics than those of systemic amyloidosis. In this paper, we present the case of a middle-aged woman who presented with worsening ulnar nerve palsy. Electrophysiological examination and MRI indicated a tumor surrounding the ulnar nerve in the forearm. However, the operative findings revealed that ulnar nerve fascicles were replaced with a yellow tissue, which was diagnosed as amyloid light-chain λ amyloidosis, based on histopathological examination. Systemic amyloidosis was ruled out after the screening examinations. This paper is the first report of the ulnar nerve as the sole site of localized immunoglobulin light-chain amyloidosis manifestation.
Keywords: Amyloid; Neuropathy; Ulnar nerve.
Copyright © 2021 by S. Karger AG, Basel.
Conflict of interest statement
All the authors have no conflicts of interest to disclose.
Figures




Similar articles
-
Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.Clin Exp Immunol. 1996 Nov;106(2):362-6. doi: 10.1046/j.1365-2249.1996.d01-830.x. Clin Exp Immunol. 1996. PMID: 8918586 Free PMC article. Review.
-
Coexistence of beta2 microglobulin and lambda light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis.Br J Dermatol. 2002 Sep;147(3):549-53. doi: 10.1046/j.1365-2133.2002.04940.x. Br J Dermatol. 2002. PMID: 12207599
-
Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom.Clin J Gastroenterol. 2016 Aug;9(4):243-51. doi: 10.1007/s12328-016-0664-5. Epub 2016 Jun 18. Clin J Gastroenterol. 2016. PMID: 27318996
-
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.Elife. 2020 Mar 10;9:e52300. doi: 10.7554/eLife.52300. Elife. 2020. PMID: 32151314 Free PMC article.
-
Localized AL amyloidosis of the colon and clinical features of intestinal obstruction. A case report.Ann Ital Med Int. 1999 Jan-Mar;14(1):58-60. Ann Ital Med Int. 1999. PMID: 10528427 Review.
References
-
- Paccalin M, Hachulla E, Cazalet C, Tricot L, Carreiro M, Rubi M, et al. Localized amyloidosis: a survey of 35 French cases. Amyloid. 2005 Dec;12((4)):239–45. - PubMed
-
- Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA. Immunoglobulin light chain amyloidosis. Expert Rev Hematol. 2014 Feb;7((1)):143–56. - PubMed
-
- Gertz MA. Immunoglobulin light chain amyloidosis: 2018 update on diagnosis, prognosis, and treatment. Am J Hematol. 2018 Sep;93((9)):1169–80. - PubMed
-
- Kelly JJ, Jr, Kyle RA, O'Brien PC, Dyck PJ. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol. 1979 Jul;6((1)):1–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources